New data from J&J’s bladder cancer drug-device trial strengthens support for NDA
Johnson & Johnson (J&J) has reported more data supporting the efficacy of its intravesical drug release system TAR-200 in patients…
News
US FDA approves BlackfinBio’s gene therapy trial for hereditary spastic paraplegia
ALX Oncology’s CD47-blocker and Keytruda combo fails in two Phase II trials
Kardium reports strong PFA system trial results
Pfizer’s sasanlimab and BCG combo therapy improves EFS in bladder cancer trial
MSD reports outcomes from Keytruda combination trial for head and neck cancer
CERo announces SCRI as main site for trial of CER-1236 to treat AML
Caribou cuts pipeline and workforce to focus on lead CAR-T programmes
